CNine Biosolutions, LLC — Form D/A
CNine Biosolutions, LLC of BIRMINGHAM, AL, a company, filed a Form D amendment with the SEC on 2018-11-08. The offering totals $2.0M, of which $1.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-11-08
- Form: D/A
- Accession: 0001725170-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $1.6M
- Remaining: $400K
- Minimum investment: $20K
- Investors: 9
- Date of first sale: 2017-12-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-300562
Issuer
- Name: CNine Biosolutions, LLC
- CIK: 0001725170
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 1040 31ST STREET SOUTH, BIRMINGHAM, AL, 35205
- Phone: 205-903-0199
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Scott R Barnum | Director | Birmingham, AL |
| Baird M Oldfield | Director | Mt. Pleasant, SC |
| Theresa N Schein | Director | Anchorage, AK |
| Scott R Barnum | Executive Officer | Birmingham, AL |
| James M Johnston | Executive Officer | Birmingham, AL |
| Theresa N Schein | Executive Officer | Anchorage, AK |
Other filings by this issuer (1)
More